OHSU's heart transplant team and senior leadership remain fully committed to and focused on ensuring heart transplant patients have immediate and ongoing care.
New findings reveal a substantial proportion of pharmaceutical industry payments to authors of oncology clinical trials published in major scientific journals are not disclosed.